Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Immune globulin intravenous, human
Every register, a page at a time. Strengths and packs are on each medicine’s page.
92 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Immune Globulin Intravenous (Human) 5% | Canada | 50 MG / ML | Liquid | Cancelled | Bayer Corporation |
| Immune Globulin Intravenous (Human), 5% | Canada | 5 G / 100 ML | Solution | Cancelled | Talecris Biotherapeutics INC |
| Yimmugo | United States | 5G/50ML | For Injection | Marketed | Biotest AG |
| Yimmugo | United States | 10G/100ML | For Injection | Marketed | Biotest AG |
| Yimmugo | United States | 20G/200ML | For Injection | Marketed | Biotest AG |
| Immune Globulin Intravenous (Human), 10% | Canada | 10 G / 100 ML | Solution | Cancelled | Talecris Biotherapeutics INC |
| Alyglo | United States | 10% 100MG/ML | Injection | Marketed | GC Biopharma Corp. |
| Asceniv | United States | 5G/50ML | Injection | Marketed | ADMA Biologics, Inc. |
| Gammagard, Gammagard S/D, Iveegam | United States | 5.0G | For Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Gammagard, Gammagard S/D, Iveegam | United States | 10G | For Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Gammaplex | United States | 20G/200ML | Injection | Marketed | Bio Products Laboratory Limited |
| Gammaplex | United States | 5G/50ML | Injection | Marketed | Bio Products Laboratory Limited |
| Gammaplex | United States | 10G/100ML | Injection | Marketed | Bio Products Laboratory Limited |
| Anthrasil | United States | >=60 U | Injection | Marketed | Emergent BioSolutions Canada Inc. |
| BabyBig | United States | 100MG | For Injection | Marketed | California Department of Public Health (CDPH) |
| Bivigam | United States | 5GM/50ML | Injection | Marketed | ADMA Biologics, Inc. |
| Bivigam | United States | 10GM/100ML | Injection | Marketed | ADMA Biologics, Inc. |
| Cnj-016 | United States | >=50,000U | Injection | Marketed | Emergent BioSolutions Canada Inc. |
| Cytogam | United States | 2.5G/50ML | Injection | Marketed | Kamada Ltd. |
| Flebogamma 5%, Flebogamma 5% Dif | United States | 10G/200ML | Injection | Marketed | Instituto Grifols, S.A. |
| Flebogamma 5%, Flebogamma 5% Dif | United States | 20G/400ML | Injection | Marketed | Instituto Grifols, S.A. |
| Flebogamma 5%, Flebogamma 5% Dif | United States | 5G/100ML | Injection | Marketed | Instituto Grifols, S.A. |
| Octagam | United States | 5% 1.0G | Injection | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Octagam | United States | 10% 2G | Injection | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Octagam | United States | 5% 5.0G | Injection | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 5
- Companies
- 3